About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Lorazepam

Company: University of California, Davis
Mechanism: Mechanism not yet reported
Route: Route not yet reported
Recruiting trials: 14 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

14 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Sep 15, 2026

Trial details

Recruiting NCT NCT04530734

Blood Concentration in Lorazepam and Treatment in Adult Catatonia

University Hospital, Lille 100 participants Est. completion 2027-01 1 site

Other conditions: Catatonia
View official trial listing →
Recruiting NCT NCT05317000

5-Azacytidine and/or Nivolumab in Resectable HPV-Associated HNSCC

Not yet reported Barbara Burtness 50 participants Est. completion 2028-11-30 1 site Stand-alone

Other conditions: Squamous Cell Carcinoma of Head and Neck
View official trial listing →
Recruiting NCT NCT05876117

Premedication for Claustrophobic Patients for MRI Scan

Salem Anaesthesia Pain Clinic 50 participants Est. completion 2025-12-31 1 site

Other conditions: Claustrophobia
View official trial listing →
Recruiting NCT NCT06004115

Processes and Circuitry Underlying Threat Sensitivity as a Treatment Target for Co-morbid Anxiety and Depression

Not yet reported Laureate Institute for Brain Research, Inc. 165 participants Est. completion 2027-12-31 1 site Stand-alone

Other conditions: Depression, Anxiety, Fear, Depression, Anxiety and Fear, Anxiety Disorders, Anxious Depression
View official trial listing →
Recruiting NCT NCT06467474

Psychoeducational Group for Depression

Not yet reported Ricardo Alberto Moreno, M.D., Ph.D. 338 participants Est. completion 2026-12-01 1 site Stand-alone

Other conditions: Major Depressive Disorder (MDD
View official trial listing →
Recruiting NCT NCT06549426

Treatment of ELectroencephalographic STatus Epilepticus After Cardiopulmonary Resuscitation-2 (TELSTAR-2)

Not yet reported University of Twente 150 participants Est. completion 2030-12 21 sites

Other conditions: Coma, Electrographic Status Epilepticus
View official trial listing →
Recruiting NCT NCT06591091

Clemastine for Improving White Matter and Boosting Antidepressant Response in Late-life Depression

Not yet reported University of Illinois at Chicago 80 participants Est. completion 2026-12 1 site Stand-alone

Other conditions: Depression
View official trial listing →
Recruiting NCT NCT06722638

Virtual Reality During Lumbar Punctures in Acute Lymphoblastic Leukemia

Not yet reported Children's National Research Institute 40 participants Est. completion 2026-12 1 site Stand-alone

Other conditions: Acute Lymphoblastic Leukemia, Pediatric
View official trial listing →
Recruiting NCT NCT06752616

Acute Agitation in Emergency Psychiatry

Not yet reported, Not yet reported Lone Baandrup 132 participants Est. completion 2027-12 1 site

Other conditions: Agitation
View official trial listing →
Recruiting NCT NCT06799494

HPV Vaccine Reduced Dose

Not yet reported Emory University 100 participants Est. completion 2028-09 1 site Stand-alone

Other conditions: HPV
View official trial listing →
Recruiting NCT NCT06852469

Computational Assessment of GABA Receptor Modulation in PTSD

Not yet reported VA Office of Research and Development 150 participants Est. completion 2029-06-30 1 site Stand-alone

Other conditions: Stress Disorders, Post-Traumatic
View official trial listing →
Recruiting NCT NCT06859424

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

Not yet reported Center for International Blood and Marrow Transplant Research 358 participants Est. completion 2028-06 13 sites Stand-alone

Other conditions: AML (Acute Myelogenous Leukemia), Acute Lymphoid Leukemia (ALL), Acute Leukemia (Category), MDS (Myelodysplastic Syndrome), CML (Chronic Myelogenous Leukemia), CLL (Chronic Lymphocytic Leukemia), Prolymphocyctic Leukemia, Chronic Myelomonocytic Leukemia (CMML), Myeloproliferative Neoplasm (MPN), Lymphoma, Myelofibrosis
View official trial listing →
Recruiting NCT NCT07552246

Comparing Acupuncture With Medication to Reduce Depression, Anxiety and Comorbid Sleep Disorders in China

Not yet reported Duke Kunshan University 180 participants Est. completion 2027-12-31 1 site

Other conditions: Anxiety Depression, Sleep
View official trial listing →
Recruiting NCT NCT07560878

Synaptic Mechanisms of Continuous Theta Burst Stimulation in Depression

Not yet reported Mclean Hospital 80 participants Est. completion 2030-12 1 site Stand-alone

Other conditions: Major Depression
View official trial listing →
Completed NCT NCT00000441

Drug Therapy for Alcohol Detoxification

Not yet reported National Institute on Alcohol Abuse and Alcoholism (NIAAA) Est. completion 2000-12 1 site

Other conditions: Alcoholism
View official trial listing →
Completed NCT NCT00004297

Phase III Randomized Study of Diazepam Vs Lorazepam Vs Placebo for Prehospital Treatment of Status Epilepticus

Not yet reported National Institute of Neurological Disorders and Stroke (NINDS) 210 participants Est. completion 1999-02

Other conditions: Status Epilepticus
View official trial listing →
Completed NCT NCT00011297

Comparing Gabapentin and Lorazepam for Treating Alcohol Withdrawal

Not yet reported National Institute on Alcohol Abuse and Alcoholism (NIAAA) 160 participants Est. completion 2005-12 1 site

Other conditions: Alcoholism
View official trial listing →
Completed NCT NCT00044642

Lorazepam-Induced Toxicity in the Aged

Not yet reported Nathan Kline Institute for Psychiatric Research 90 participants Est. completion 2007-07 2 sites

Other conditions: Anxiety Disorders, Generalized Anxiety Disorder
View official trial listing →
Completed NCT NCT00055549

Dextromethorphan to Treat Patients With Voice Spasms

Not yet reported National Institute of Neurological Disorders and Stroke (NINDS) 65 participants Est. completion 2009-11-13 1 site

Other conditions: Voice Disorders
View official trial listing →
Completed NCT NCT00095251

MENDS Study: Trial in Ventilated ICU Patients Comparing an Alpha2 Agonist Versus a Gamma Aminobutyric Acid (GABA)-Agonist to Determine Delirium Rates, Efficacy of Sedation, Analgesia and Discharge Cognitive Status

Not yet reported Vanderbilt University 100 participants Est. completion 2016-12 1 site

Other conditions: Delirium
View official trial listing →
Completed NCT NCT00109395

Lorazepam Sedation for Critically Ill Children

Not yet reported, Not yet reported The Emmes Company, LLC 179 participants Est. completion 2007-09 1 site

Other conditions: Critical Illness
View official trial listing →
Completed NCT NCT00114569

Lorazepam for the Treatment of Status Epilepticus in Children

Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 69 participants Est. completion 2009-02 1 site

Other conditions: Status Epilepticus
View official trial listing →
Completed NCT NCT00116064

Intranasal Lorazepam Versus Intramuscular Paraldehyde in Paediatric Convulsions

Not yet reported Kamuzu University of Health Sciences 156 participants Est. completion 2005-06 1 site

Other conditions: Status Epilepticus, Convulsions
View official trial listing →
Withdrawn NCT NCT00123578

GHB Withdrawal Symptoms and Effectiveness of Treatment With Lorazepam Versus Pentobarbital - 1

Not yet reported, Not yet reported University of California, Los Angeles Est. completion 2008-08 1 site Stand-alone

Substance use disorder
View official trial listing →
Completed NCT NCT00158873

Pharmaco-Economic Study Of Ultiva In Intensive Care Unit(ICU)Subjects

Not yet reported GlaxoSmithKline 224 participants 15 sites

Other conditions: Sedation
View official trial listing →
Completed NCT NCT00159133

Prodrome-Based Early Intervention With Antipsychotics vs. Benzodiazepines in First-Episode Schizophrenia

Not yet reported Heinrich-Heine University, Duesseldorf 71 participants Est. completion 2006-06 1 site Stand-alone

Other conditions: Schizophrenia, Psychoses
View official trial listing →
Completed NCT NCT00229125

Comparing the Treatment of Alcohol Withdrawal Syndrome Using Gabapentin Versus Lorazepam

Not yet reported National Institute on Alcohol Abuse and Alcoholism (NIAAA) 160 participants Est. completion 2005-09 1 site

Other conditions: Alcohol Withdrawal Syndrome(AWS)
View official trial listing →
Completed NCT NCT00249171

A Study of Risperidone in Combination With Lorazepam Compared With Standard Therapy for Emergency Treatment of Schizophrenic Patients

Not yet reported Janssen Pharmaceutica N.V., Belgium 226 participants Est. completion 2003-02

Other conditions: Schizophrenia, Psychotic Disorders, Emergency Treatment
View official trial listing →
Completed NCT NCT00249366

Treatment of Alcohol Withdrawal in Hospital Patients

Not yet reported Virginia Commonwealth University 183 participants Est. completion 2003-05 1 site

Other conditions: Alcohol Withdrawal Syndrome
View official trial listing →
Terminated NCT NCT00337792

Comparing the Effectiveness of Oral Versus Intravenous Pain Medicine for Suction Curettage (D&C)

Not yet reported Planned Parenthood League of Massachusetts 132 participants Est. completion 2007-07 1 site

Other conditions: Undesired Pregnancy
View official trial listing →
Terminated NCT NCT00343096

Randomized Trial Comparing 3 Routes of Delivering Lorazepam to Children.

Not yet reported Kamuzu University of Health Sciences 800 participants Est. completion 2009-03 1 site

Other conditions: Status Epilepticus, Convulsions
View official trial listing →
Terminated NCT NCT00364429

SPECT Investigation Of The NMDA Receptor System In Healthy Volunteers And Patients With Schizophrenia

Not yet reported GlaxoSmithKline 55 participants Est. completion 2005-07 1 site

Other conditions: Schizophrenia
View official trial listing →
Completed NCT NCT00424697

A Study to Investigate the Effects of GW876008 on Brain Activation During Emotional Processing in Healthy Subjects.

Not yet reported GlaxoSmithKline 26 participants Est. completion 2007-12 1 site

Other conditions: Healthy Subjects
View official trial listing →
Terminated NCT NCT00429702

Diphenhydramine, Lorazepam, and Dexamethasone in Treating Nausea and Vomiting Caused By Chemotherapy

Not yet reported University of South Florida 7 participants Est. completion 2009-11 7 sites Stand-alone

Other conditions: Nausea, Vomiting, Unspecified Childhood Solid Tumor, Protocol Specific
View official trial listing →
Completed NCT NCT00431184

Effects of Pentazocine Versus Lorazepam on Manic Symptoms

Not yet reported Mclean Hospital 19 participants Est. completion 2011-03 1 site

Other conditions: Bipolar Disorder, Schizoaffective Disorder, Manic Disorder, Mania, Manic State
View official trial listing →
Completed NCT NCT00457366

A Comparison Study of the Efficacy of Quetiapine and Haloperidol in Agitated Adults in Emergency Room

Not yet reported University of Southern California 72 participants Est. completion 2009-05 1 site

Other conditions: Agitation
View official trial listing →
Withdrawn NCT NCT00465244

Seizure Therapy With Intravenous Levetiracetam and Lorazepam

Not yet reported, Not yet reported Massachusetts General Hospital Est. completion 2010-05 Stand-alone

Other conditions: Seizures
View official trial listing →
Completed NCT NCT00496340

Phase II Trial of Pentostatin and Targeted Busulfan

Not yet reported H. Lee Moffitt Cancer Center and Research Institute 42 participants Est. completion 2013-08 1 site Stand-alone

Other conditions: Hematologic Malignancies
View official trial listing →
Completed NCT NCT00513565

A Study To Investigate Effects Of GSK561679 On Brain Activation During Emotional Processing In Healthy Volunteers

Not yet reported GlaxoSmithKline 22 participants Est. completion 2009-05-14 1 site Stand-alone

Other conditions: Depressive Disorder and Anxiety Disorders
View official trial listing →
Completed NCT NCT00523185

A Comparison of Lorazepam and Diazepam in the Treatment of Alcohol Withdrawal

Not yet reported Stanford University 55 participants Est. completion 2004-11 2 sites

Other conditions: Alcohol Withdrawal
View official trial listing →
Completed NCT NCT00546624

GEM 1.5 mg b.i.d. to 4.5 mg b.i.d. Versus Lorazepam in GAD (0777-026)

Not yet reported Merck Sharp & Dohme LLC 38 participants Est. completion 2003-02

Other conditions: Anxiety Disorder
View official trial listing →
Terminated NCT NCT00580151

The Use of Clonidine in Pain and Anxiety Associated With Acute Burn Injury in Children

Not yet reported The University of Texas Medical Branch, Galveston 9 participants Est. completion 2014-06 1 site

Other conditions: Pain, Anxiety
View official trial listing →
Completed NCT NCT00586430

The Impact of Lorazepam on Cognition in APOE e4 Carriers

Not yet reported Mayo Clinic 36 participants Est. completion 2007-07 1 site

Other conditions: Alzheimer's Disease
View official trial listing →
Completed NCT NCT00587964

Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases

Not yet reported Memorial Sloan Kettering Cancer Center 51 participants Est. completion 2009-01 1 site Stand-alone

Other conditions: Brain Metastasis, Bladder Cancer, Breast Cancer, Cervical Cancer, Colon Cancer, HEENT Cancer, Lung Cancer, Melanoma, Pancreatic Cancer, Prostate Cancer, Rectal Cancer, Sarcoma, Testicular Cancer
View official trial listing →
Completed NCT NCT00597701

Treating Alcohol Withdrawal With Oral Baclofen

Not yet reported Essentia Health 79 participants Est. completion 2008-02 1 site

Other conditions: Alcohol Withdrawal Delirium
View official trial listing →
Completed NCT NCT00600353

Multi-day Doses in Prevention of Nausea and Emesis

Not yet reported University of Kansas Medical Center 20 participants Est. completion 2010-01 1 site Stand-alone

Other conditions: Myeloma, Plasma-Cell, Lymphoma, Malignant
View official trial listing →
Withdrawn NCT NCT00603135

Intravenous Levetiracetam as First-line Anticonvulsive Treatment in Patients With Non-convulsive Status Epilepticus

Not yet reported University Hospital, Basel, Switzerland Est. completion 2010-03 1 site Stand-alone

Other conditions: Status Epilepticus, Non-Convulsive
View official trial listing →
Completed NCT NCT00613067

ERP N1 as a Treatment Predictor of Generalized Anxiety Disorder

Not yet reported Inje University 35 participants Est. completion 2010-05 1 site Stand-alone

Other conditions: Generalized Anxiety Disorder
View official trial listing →
Completed NCT NCT00619879

Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies

Ann & Robert H Lurie Children's Hospital of Chicago 81 participants Est. completion 2019-02-07 1 site

Other conditions: Leukemia, Myelogenous, Chronic, Leukemia, Lymphoblastic, Acute, Leukemia, Myelogenous, Acute, Myeloproliferative-Myelodysplastic Diseases, Lymphoma, Malignant
View official trial listing →
Completed NCT NCT00621478

Efficacy and Safety Study Comparing Lorazepam and Diazepam for Children in the Emergency Department With Seizures (Status 2)

Not yet reported, Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 259 participants Est. completion 2012-05 14 sites

Other conditions: Status Epilepticus
View official trial listing →
Completed NCT NCT00624780

Safety and Efficacy Evaluation Of Pregabalin (Lyrica) With Patients With Generalized Anxiety Disorder

Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 615 participants Est. completion 2012-04 57 sites

Other conditions: Generalized Anxiety Disorder
View official trial listing →
Completed NCT NCT00641797

Treating Benign Paroxysmal Positional Vertigo (BPPV) in ED Patients

Not yet reported Lehigh Valley Hospital 26 participants Est. completion 2013-11 1 site

Other conditions: Benign Paroxysmal Positional Vertigo
View official trial listing →
Completed NCT NCT00649818

Fasting Study of Lorazepam Tablets 2 mg and Ativan Tablets 2 mg

Not yet reported Mylan Pharmaceuticals Inc 28 participants Est. completion 2004-12 1 site Stand-alone

Other conditions: Healthy
View official trial listing →
Completed NCT NCT00696033

Exploring the Effects of Diazepam and Lorazepam

Not yet reported University Hospital, Strasbourg, France 22 participants Est. completion 2008-12 2 sites Stand-alone

Other conditions: Healthy Subjects
View official trial listing →
Completed NCT NCT00714194

Effect of Daily Interruption of Continuous Sedation on Delirium, Sleep Perception in Intensive Care Unit (ICU) Patients

Not yet reported University of California, San Francisco 52 participants Est. completion 2009-09 1 site Stand-alone

Other conditions: Delirium, Sleep Perception
View official trial listing →
Completed NCT NCT00715039

Clinical Study Assessing a New Scale to Measure Onset of Action in Generalized Anxiety Disorder

Not yet reported Pfizer 169 participants Est. completion 2004-05 15 sites

Other conditions: Anxiety Disorders
View official trial listing →
Completed NCT NCT00720421

A Sedation/Cognition/Electroencephalogram (EEG) Study Using AZD7325 and Comparator.

Not yet reported AstraZeneca 16 participants Est. completion 2008-08 1 site

Other conditions: Healthy Volunteer
View official trial listing →
Completed NCT NCT00721526

Disulfiram Combined With Lorazepam for Alcohol Dependence and Anxiety Disorder

Not yet reported University of New Mexico 41 participants Est. completion 2012-08 1 site Stand-alone

Alcohol use disorder Other conditions: Anxiety Disorder
View official trial listing →
Completed NCT NCT00735527

Nasal Versus Venous Lorazepam for Control of Acute Seizures in Children

Not yet reported All India Institute of Medical Sciences 140 participants Est. completion 2009-04 1 site Stand-alone

Other conditions: Status Epilepticus, Seizures
View official trial listing →
Completed NCT NCT00736931

Clinical Study in Healthy Volunteers to Investigate the Neurocognitive Effects of a New Antiepileptic Drug: Brivaracetam

Not yet reported UCB Pharma 20 participants Est. completion 2008-10 1 site Stand-alone

Other conditions: Epilepsy
View official trial listing →
Completed NCT NCT00750802

A Sedation/Cognition/EEG Study Using AZD6280 and Comparator

Not yet reported AstraZeneca 17 participants Est. completion 2008-12 1 site

Other conditions: Healthy Volunteer
View official trial listing →
Withdrawn NCT NCT00786318

Ziprasidone vs Standard Therapy for Agitated Patients in the ED

Not yet reported George Washington University Est. completion 2011-07 1 site

Other conditions: Psychosis, Agitation, Delirium
View official trial listing →
Completed NCT NCT00797277

Intramuscular (IM) Olanzapine Versus IM Haloperidol Plus Lorazepam for Acute Agitation in Schizophrenia

Not yet reported National Taiwan University Hospital 67 participants Est. completion 2009-06 1 site

Other conditions: Schizophrenia, Schizoaffective Disorder, Agitation
View official trial listing →
Completed NCT NCT00807937

Proof of Concept in Patients With Generalized Anxiety Disorder (GAD)AZD7325

Not yet reported AstraZeneca 369 participants Est. completion 2009-05 51 sites

Other conditions: Anxiety Disorders
View official trial listing →
Completed NCT NCT00809146

Paramedic Treatment of Prolonged Seizures by Intramuscular Versus Intravenous Anticonvulsant Medications

Not yet reported Robert Silbergleit 1023 participants Est. completion 2011-01 17 sites

Other conditions: Status Epilepticus
View official trial listing →
Terminated NCT NCT00826553

How Your Patients' Non-REM Sleep Changes On Sedatives in the Intensive Care Units

Not yet reported Vanderbilt University Medical Center 6 participants Est. completion 2013-12 1 site

Other conditions: Delirium, Respiratory Failure
View official trial listing →
Completed NCT NCT00846950

Effects of H1-Antagonist on Cognition

Not yet reported Maastricht University Medical Center 18 participants Est. completion 2007-05 1 site Stand-alone

Other conditions: Cognition
View official trial listing →
Terminated NCT NCT00881556

Allogeneic Stem Cell Transplantation (ALLOSCT) in Recessive Dystrophic Epidermolysis Bullosa (RDEB)

Not yet reported Columbia University 3 participants Est. completion 2015-09 3 sites Stand-alone

Obstructive sleep apnea
View official trial listing →
Completed NCT NCT00902772

Study to Evaluate the Abuse Potential of AZD7325 in Healthy Recreational Central Nervous System (CNS) Depressant Users

Not yet reported AstraZeneca 100 participants Est. completion 2009-09 1 site

Other conditions: Recreational CNS Depressant Use
View official trial listing →
Completed NCT NCT00904618

Safety and Efficacy Study on the Implantation of the Tension-Free Vaginal Tape (TVT-Secur) Under Local Anesthesia

Not yet reported Université de Sherbrooke 48 participants Est. completion 2009-03 1 site Stand-alone

Other conditions: Urinary Stress Incontinence
View official trial listing →
Completed NCT NCT00972985

Acute Effect of Three Neuroactive Drugs Measured by Magnetoencephalography (MEG), Electroencephalography (EEG) and the Synchronous Neural Interaction Test

Not yet reported Orasi Medical, Inc. 15 participants Est. completion 2009-12 1 site Stand-alone

Other conditions: Healthy
View official trial listing →
Terminated NCT NCT01011634

Trial Comparing Intravenous and Oral Moderate Sedation for First Trimester Surgical Abortions

Not yet reported University of California, San Francisco 18 participants Est. completion 2008-11 1 site

Other conditions: Undesired Intrauterine Pregnancy, First Trimester Pregnancy
View official trial listing →
Terminated NCT NCT01019681

Efficacy and Safety of Umbilical Cord Blood Injection for Critical Limb Ischemia

Not yet reported Richard Burt, MD 1 participants Est. completion 2014-01 1 site Stand-alone

Other conditions: Critical Limb Ischemia
View official trial listing →
Completed NCT NCT01030874

Orthostatic Hypotension Treatment on Rehab Unit

Not yet reported VA Office of Research and Development 356 participants Est. completion 2016-05 1 site Stand-alone

Other conditions: Orthostatic Hypotension, Falls
View official trial listing →
Completed NCT NCT01050478

IMPACT: A Study to Explore the Efficacy and Safety of Paliperidone ER in Patients With Acute Agitation

Not yet reported Janssen Cilag N.V./S.A. 56 participants Est. completion 2011-12 14 sites Stand-alone

Other conditions: Psychomotor Agitation, Acute Disease
View official trial listing →
Terminated NCT NCT01067144

Stanford Accelerated Recovery Trial (START)

Not yet reported Stanford University 422 participants Est. completion 2016-07 1 site

Other conditions: Pain, Breast Cancer, Lung Cancer
View official trial listing →
Completed NCT NCT01110616

EEG (Electroencephalogram) Platform Standardization in Healthy Male Subjects (3134-010)

Not yet reported Merck Sharp & Dohme LLC 25 participants Est. completion 2010-10 Stand-alone

Other conditions: Dementia
View official trial listing →
Terminated NCT NCT01111942

A Pilot Study of Induction Chemotherapy Followed by Surgery for Locally Advanced Resectable Head and Neck Cancer

Not yet reported Southern Illinois University 4 participants Est. completion 2014-01 1 site

Other conditions: Head and Neck Cancer
View official trial listing →
Status unknown NCT NCT01121055

Effect of Additive Lorazepam on Patient Satisfaction as a Premedication in Diagnostic Flexible Bronchoscopy

Not yet reported Seoul National University Hospital 372 participants Est. completion 2010-12 1 site Stand-alone

Other conditions: Patient Satisfaction for Bronchoscopy
View official trial listing →
Completed NCT NCT01198353

Effectiveness of Ziprasidone for Patients With Schizophrenia

Not yet reported Soonchunhyang University Hospital 67 participants Est. completion 2013-12 6 sites Stand-alone

Other conditions: Schizophrenia, Schizoaffective Disorder
View official trial listing →
Completed NCT NCT01204255

Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol Gel in Healthy Volunteers

Not yet reported Virginia Commonwealth University 11 participants Est. completion 2011-05-17 1 site Stand-alone

Other conditions: Healthy
View official trial listing →
Completed NCT NCT01212185

Oxytocin Treatment of Alcohol Withdrawal

Not yet reported University of North Carolina, Chapel Hill 14 participants Est. completion 2011-03 2 sites

Other conditions: Alcohol Withdrawal
View official trial listing →
Status unknown NCT NCT01272778

Acute Effect of Lorazepam on Brain Activity Measured by Magnetoencephalograpy (MEG) and Electroencephalography (EEG)

Not yet reported Orasi Medical, Inc. 16 participants Est. completion 2011-04 1 site Stand-alone

Other conditions: Healthy Subjects
View official trial listing →
Completed NCT NCT01275144

A Study of the Effect of LY2216684 on Lorazepam

Not yet reported Eli Lilly and Company 28 participants Est. completion 2011-02 1 site Stand-alone

Other conditions: Major Depressive Disorder
View official trial listing →
Terminated NCT NCT01305707

Continuation Electroconvulsive Therapy (C-ECT) for Relapse Prevention in Major Depression

Not yet reported Hospital Universitari de Bellvitge 104 participants Est. completion 2014-07 3 sites

Other conditions: Depression
View official trial listing →
Completed NCT NCT01330459

Hydrocodone For Pain Control in First Trimester Surgical Abortion

Not yet reported Elizabeth Micks 121 participants Est. completion 2011-10 2 sites

Other conditions: Pain
View official trial listing →
Completed NCT NCT01349907

Extension Study of Asenapine [P06107 (NCT01244815)] for Pediatric Bipolar Disorder (P05898)

Not yet reported Organon and Co 322 participants Est. completion 2014-09-05 Stand-alone

Other conditions: Bipolar Disorder
View official trial listing →
Status unknown NCT NCT01360346

Enteral Versus Intravenous Sedation in Critically Ill High-risk ICU Patients

Not yet reported University of Milan 300 participants Est. completion 2012-12 1 site Stand-alone

Other conditions: Critical Illness, Mechanical Ventilation Complication
View official trial listing →
Terminated NCT NCT01362205

Dexmedetomidine (Precedex®) for Severe Alcohol Withdrawal Syndrome (AWS) and Alcohol Withdrawal Delirium (AWD)

Not yet reported Denver Health and Hospital Authority 49 participants Est. completion 2016-09 7 sites Stand-alone

Other conditions: Alcohol Withdrawal Delirium, Alcohol Withdrawal Associated Autonomic Hyperactivity, Alcohol Withdrawal Hallucinosis, Alcohol Withdrawal-Induced Delirium Tremens
View official trial listing →
Completed NCT NCT01391962

Sunitinib or Cediranib for Alveolar Soft Part Sarcoma

Not yet reported National Cancer Institute (NCI) 34 participants Est. completion 2026-01-16 1 site

Other conditions: Sarcoma, Alveolar Soft Part
View official trial listing →
Withdrawn NCT NCT01393288

Developing Individualized Strategies to Prevent Nausea and Vomiting

Not yet reported University of California, San Francisco Est. completion 2015-11 6 sites

Other conditions: Postoperative Nausea and Vomiting, Genetic Polymorphisms
View official trial listing →
Completed NCT NCT01441843

Resistance Under the Microscope

Not yet reported Erasmus Medical Center 400 participants Est. completion 2011-09 1 site

Other conditions: Anxiety
View official trial listing →
Completed NCT NCT01505569

Auto Transplant for High Risk or Relapsed Solid or CNS Tumors

Not yet reported Masonic Cancer Center, University of Minnesota 44 participants Est. completion 2024-02-01 1 site

Obstructive sleep apnea Other conditions: Ewing's Family Tumors, Renal Tumors, Hepatoblastoma, Soft Tissue Sarcoma, Primary Malignant Brain Neoplasms, Retinoblastoma, Medulloblastoma, Supra-tentorial Primative Neuro-Ectodermal Tumor (PNET), Atypical Teratoid/Rhabdoid Tumor (AT/RT), CNS Tumors, Germ Cell Tumors
View official trial listing →
Completed NCT NCT01556932

Randomized Trial of the Effectiveness of Topical "ABH Gel" vs. Placebo in Cancer Patients With Nausea

Not yet reported Virginia Commonwealth University 22 participants Est. completion 2014-05 1 site

Other conditions: Nausea, Vomiting
View official trial listing →
Completed NCT NCT01566539

Biological Basis of Individual Variation in Social Cooperation

Not yet reported Emory University 707 participants Est. completion 2016-11 2 sites Stand-alone

Other conditions: Healthy
View official trial listing →
Status unknown NCT NCT01684085

Explanation About Sleep in Post Trauma Patients

Not yet reported Sheba Medical Center 70 participants 1 site

Other conditions: Post Traumatic Stress Disorder, Sleep Deprivation
View official trial listing →
Completed NCT NCT01780519

The Cognitive Effects of Lorazepam in Healthy Older Individuals With TOMM40 Variable-length Polymorphisms

Not yet reported Mayo Clinic 57 participants Est. completion 2016-09 1 site

Other conditions: Alzheimer's Disease (AD)
View official trial listing →
Completed NCT NCT01790490

Glutamatergic Modulation of Cocaine-related Deficits

Not yet reported New York State Psychiatric Institute 8 participants Est. completion 2012-03 1 site Stand-alone

Other conditions: Cocaine Dependence
View official trial listing →
Completed NCT NCT01810458

Liver Fibrosis in Alpha-1 Antitrypsin Deficiency (Liver AATD)

University of Florida 109 participants Est. completion 2019-09 1 site

Other conditions: Liver Fibrosis, Alpha-1 Antitrypsin Deficiency, AAT Deficiency, AATD
View official trial listing →
Completed NCT NCT01827293

Promethazine vs. Lorazepam for Treatment of Vertigo

Not yet reported Shahid Beheshti University of Medical Sciences 210 participants Est. completion 2013-06 1 site

Other conditions: Peripheral Vertigo.
View official trial listing →
Withdrawn NCT NCT01843868

Emesis Control Study in Non-Hodgkin Lymphoma Patients Receiving R-CHOP

Not yet reported Australasian Leukaemia and Lymphoma Group Est. completion 2015-06

Other conditions: Lymphoma, Non-Hodgkin
View official trial listing →
Completed NCT NCT01870024

Comparison Between Lorazepam, Clonazepam and Clonazepam + Fosphenytoin for the Treatment of Out-of-hospital Generalized Status Epilepticus

Not yet reported Assistance Publique - Hôpitaux de Paris 434 participants Est. completion 2018-02-23 1 site

Other conditions: Status Epilepticus, Epilepsy
View official trial listing →
Completed NCT NCT01877642

ADASUVE-Lorazepam Drug-Drug Interaction

Not yet reported Alexza Pharmaceuticals, Inc. 22 participants Est. completion 2013-07 1 site

Other conditions: Healthy Volunteers
View official trial listing →
Completed NCT NCT01889602

Characterizing and Predicting Drug Effects on Cognition

Not yet reported University of Minnesota 60 participants Est. completion 2016-08 1 site Stand-alone

Other conditions: Cognitive Deficits
View official trial listing →
Terminated NCT NCT01893632

Gabapentin Treatment of Benzodiazepine Dependence

Not yet reported New York State Psychiatric Institute 2 participants Est. completion 2016-04-01 1 site

Other conditions: Benzodiazepine Dependence
View official trial listing →
Completed NCT NCT01901003

Sedative Premedication: Efficacy On Patient Experience

Not yet reported Assistance Publique Hopitaux De Marseille 1200 participants Est. completion 2014-06 1 site Stand-alone

Other conditions: Perioperative Anxiety
View official trial listing →
Active, not recruiting NCT NCT01949662

Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer

Not yet reported M.D. Anderson Cancer Center 93 participants Est. completion 2028-01-01 1 site Stand-alone

Other conditions: Advanced Cancers
View official trial listing →
Completed NCT NCT01951144

A First In Human Study In Healthy People To Evaluate Safety, Toleration, Pharmacokinetics and Pharmacodynamics of Single Oral Doses Of PF-06372865

Not yet reported Pfizer 45 participants Est. completion 2014-07 1 site Stand-alone

Other conditions: Healthy
View official trial listing →
Completed NCT NCT01994668

Phase 1 Study to Characterize the Safety and Pharmacokinetics of Single Intravenous Dose of Lorazepam in Healthy Japanese Adult Subjects

Not yet reported Pfizer 8 participants Est. completion 2014-02 1 site Stand-alone

Other conditions: Healthy
View official trial listing →
Completed NCT NCT02033707

Effects of Hallucinogens and Other Drugs on Mood and Performance

Not yet reported Johns Hopkins University 20 participants Est. completion 2019-02 1 site Stand-alone

Other conditions: Healthy
View official trial listing →
Completed NCT NCT02056236

TELSTAR: Treatment of ELectroencephalographic STatus Epilepticus After Cardiopulmonary Resuscitation

Not yet reported University of Twente 172 participants Est. completion 2022-01-24 11 sites Stand-alone

Other conditions: Cardiac Arrest, Anoxic Encephalopathy, Status Epilepticus
View official trial listing →
Status unknown NCT NCT02078336

Optimization of Procedural Sedation Protocol Used for Dental Care Delivery in People With Mental Disability

Not yet reported Universitaire Ziekenhuizen KU Leuven 40 participants Est. completion 2025-07 1 site

Other conditions: Dental Care for Disabled
View official trial listing →
Completed NCT NCT02096575

Nitrous Oxide for Pain Management of First Trimester Surgical Abortion

Not yet reported University of New Mexico 140 participants Est. completion 2015-04 1 site Stand-alone

Other conditions: Abortion in First Trimester
View official trial listing →
Terminated NCT NCT02134366

Clobazam Use in Epilepsia Partialis Continua - Pilot Study

Not yet reported The Cooper Health System 7 participants Est. completion 2017-07 1 site Stand-alone

Other conditions: Epilepsia Partialis Continua, Kojewnikov's Epilepsy, Epilepsy
View official trial listing →
Completed NCT NCT02147548

Evaluation of the Effects of Etifoxine 100 mg and Lorazepam 2 mg on Vigilance and Cognitive Functions in the Elderly

Not yet reported Biocodex 31 participants Est. completion 2015-10 1 site

Other conditions: Healthy Volunteers
View official trial listing →
Completed NCT NCT02239380

Lorazepam for the Treatment of Status Epilepticus or Repetitive Status Epilepticus in Japan

Not yet reported Pfizer 26 participants Est. completion 2016-08 20 sites Stand-alone

Other conditions: Status Epilepticus
View official trial listing →
Completed NCT NCT02305797

EDG004 Treatment of Adult Patients With Generalized Anxiety Disorder (GAD)

Not yet reported Edgemont Pharmaceuticals, LLC 495 participants Est. completion 2016-05 1 site Stand-alone

Other conditions: Generalized Anxiety Disorder (GAD)
View official trial listing →
Completed NCT NCT02312739

Nitrous Oxide for Pain Management During In-office Transcervical Sterilization

Not yet reported University of New Mexico 72 participants Est. completion 2015-03 1 site

Other conditions: Contraception, Inhalation of Nitrous Oxide
View official trial listing →
Completed NCT NCT02362256

The Comparison of Stress Response to Rapid Opioid Detoxification Applying Different Methods of Opioid Antagonism

Not yet reported Vilnius University 60 participants Est. completion 2014-09 1 site Stand-alone

Other conditions: Opiate Addiction
View official trial listing →
Status unknown NCT NCT02367755

Therapeutic Hypothermia With Propofol in Survival and Neurological Prognoses After Cardiac Arrest

Not yet reported Far Eastern Memorial Hospital 30 participants Est. completion 2016-12 1 site

Other conditions: Hypothermia, Cardiac Arrest
View official trial listing →
Terminated NCT NCT02374567

Pharmacovigilance in Gerontopsychiatric Patients

Not yet reported Hannover Medical School 407 participants Est. completion 2017-06-28 5 sites Stand-alone

Other conditions: Dementia, Depression, Schizophrenia, Psychosomatic Disorders, Anxiety Disorders
View official trial listing →
Completed NCT NCT02407704

A Multi-level Life-span Characterization of Adult-depression and Effects of Medication and Exercise

Not yet reported Kirk Erickson, PhD 31 participants Est. completion 2016-12 1 site Stand-alone

Other conditions: Depression, Depressive Disorder, Major, Depressive Disorder, Unipolar Depression, Major Depressive Disorder
View official trial listing →
Completed NCT NCT02462109

Catatonia in Nodding Syndrome and Lorazepam Treatment

Not yet reported Makerere University 16 participants Est. completion 2013-03 Stand-alone

Other conditions: Catatonia, Nodding Syndrome
View official trial listing →
Completed NCT NCT02564029

PF-06372865 in Subjects With Photosensitive Epilepsy

Not yet reported Pfizer 7 participants Est. completion 2017-02-07 16 sites

Other conditions: Reflex Epilepsy, Photosensitive
View official trial listing →
Completed NCT NCT02593448

Influence of Cardiopulmonary Bypass, and Sevoflurane or Propofol Anesthesia, on Tissue Oxygen Saturation.

Not yet reported Medical University of Gdansk 64 participants Est. completion 2014-08 1 site Stand-alone

Other conditions: NIR Spectroscopy
View official trial listing →
Status unknown NCT NCT02648776

Risk and Benefit Assessment of Hypnotic Agents for Sleep Disorders Among Elderly

China Medical University Hospital 1400 participants Est. completion 2018-12 1 site

Other conditions: Sleep Disorders
View official trial listing →
Completed NCT NCT02671760

Pilot Study of a Combination Drug Product for Treatment of Short-term Insomnia

Not yet reported Sequential Medicine Ltd 39 participants Est. completion 2016-06 Stand-alone

Other conditions: Short-term Insomnia
View official trial listing →
Withdrawn NCT NCT02726867

Levetiracetam, Lacosamide and Ketamine as Adjunctive Treatment of Refractory Status Epilepticus

Not yet reported Mid-Atlantic Epilepsy and Sleep Center, LLC Est. completion 2016-11 1 site

Other conditions: Epilepsy, Status Epilepticus
View official trial listing →
Active, not recruiting NCT NCT02815917

Evaluation of D3 Receptor Occupancy Using FLUORTRIOPRIDE ([18F]FTP) PET/CT

Not yet reported, Not yet reported University of Pennsylvania 30 participants Est. completion 2027-06 1 site Stand-alone

Other conditions: D3 Dopamine Receptor, Cocaine-dependent, Healthy Volunteer
View official trial listing →
Completed NCT NCT02863614

Analgesia for Endometrial Scratching

Not yet reported University of Sao Paulo 150 participants Est. completion 2017-05 Stand-alone

Other conditions: Subfertility, Infertility
View official trial listing →
Status unknown NCT NCT02877108

Naturalistic Adasuve Clinical Trial Study

Mt Sinai Hospital, Chicago 100 participants Est. completion 2017-04 2 sites

Other conditions: Agitation
View official trial listing →
Status unknown NCT NCT02928328

Assessment of Peripheral GABA Receptors for Local Pain Relief

Not yet reported Aalborg University 90 participants Est. completion 2019-12 1 site Stand-alone

Other conditions: Pain
View official trial listing →
Completed NCT NCT03012815

Gabapentin for Alcohol Withdrawal Syndrome

Not yet reported Mayo Clinic 88 participants Est. completion 2021-03-01 1 site

Other conditions: Alcohol Withdrawal Syndrome
View official trial listing →
Completed NCT NCT03021018

A Study to Assess the Efficacy and Safety of Brivaracetam as Treatment for Increased Seizure Activity in an Epilepsy Monitoring Unit Setting

Not yet reported UCB Biopharma S.P.R.L. 46 participants Est. completion 2018-04-27 14 sites

Other conditions: Epilepsy
View official trial listing →
Completed NCT NCT03030417

Indenoisoquinoline LMP744 in Adults With Relapsed Solid Tumors and Lymphomas

Not yet reported National Cancer Institute (NCI) 36 participants Est. completion 2023-10-12 2 sites Stand-alone

Other conditions: Solid Tumors, Lymphoma
View official trial listing →
Completed NCT NCT03053869

Benzodiazepine-free Anesthetic for Reduction of Delirium (B-Free)

Not yet reported McMaster University 480 participants Est. completion 2018-09-30 2 sites

Other conditions: Post-operative Delirium
View official trial listing →
Completed NCT NCT03071913

Blood Brain Barrier Differences in Patients with Brain Tumors Undergoing Surgery

Mayo Clinic 54 participants Est. completion 2023-01-12 1 site

Other conditions: Central Nervous System Neoplasm, Localized Brain Neoplasm, Metastatic Malignant Neoplasm in the Brain, Recurrent Brain Neoplasm
View official trial listing →
Completed NCT NCT03090620

Treatment of Adolescent Antimuscarinic (Anticholinergic) Toxidrome

Not yet reported University of Colorado, Denver 19 participants Est. completion 2020-08-31 1 site Stand-alone

Other conditions: Anticholinergics Toxicity
View official trial listing →
Terminated NCT NCT03110900

Inhaled Loxapine vs Intramuscular (IM) Haloperidol + Lorazepam for Agitation

Not yet reported University of Arkansas 2 participants Est. completion 2018-04-04 1 site

Other conditions: Agitation,Psychomotor, Haloperidol Causing Adverse Effects in Therapeutic Use, Lorazepam Causing Adverse Effects in Therapeutic Use, Loxapine Causing Adverse Effects in Therapeutic Use
View official trial listing →
Completed NCT NCT03180632

Effect of A Single Dose of Lorazepam on Salivary Cortisol Response in Children Undergoing Digestive Endoscopy:

Not yet reported St. Justine's Hospital 98 participants Est. completion 2018-06-01 1 site

Other conditions: Anxiety
View official trial listing →
Completed NCT NCT03202550

Oral Sedation During Cervical Dilator Placement

Not yet reported Johns Hopkins University 27 participants Est. completion 2019-05-28 1 site

Other conditions: Oral Sedation and Cervical Dilator Pain
View official trial listing →
Terminated NCT NCT03235531

Assessment of Valproate on Ethanol Withdrawal

Not yet reported CAMC Health System 3 participants Est. completion 2019-06-25 2 sites Stand-alone

Alcohol use disorder Other conditions: Alcohol Withdrawal Syndrome, Trauma, Heavy Drinking
View official trial listing →
Completed NCT NCT03300947

Psilocybin for Treatment of Obsessive Compulsive Disorder

Not yet reported University of Arizona 15 participants Est. completion 2023-12-30 1 site

Other conditions: Obsessive-compulsive Disorder (OCD)
View official trial listing →
Completed NCT NCT03331042

SM-1 vs 2 Comparators and Placebo in Participants With a History of Transient Insomnia.

Not yet reported Sequential Medicine Ltd 85 participants Est. completion 2018-03-22 2 sites Stand-alone

Other conditions: Transient Insomnia
View official trial listing →
Withdrawn NCT NCT03338764

An Investigational Study to Assess Efficacy and Pattern of Use of SM-1 in Subjects With a History of Transient Insomnia

Not yet reported Sequential Medicine Ltd Est. completion 2023-12 Stand-alone

Other conditions: Transient Insomnia
View official trial listing →
Terminated NCT NCT03435692

Post Operative Pain Control After Pediatric Hip Surgery

Not yet reported Seattle Children's Hospital 42 participants Est. completion 2014-07-29 Stand-alone

Other conditions: Hip Surgery, Post Operative Pain Control
View official trial listing →
Active, not recruiting NCT NCT03743649

Haloperidol and Lorazepam in Controlling Symptoms of Persistent Agitated Delirium in Patients With Advanced Cancer Undergoing Palliative Care

Not yet reported, Not yet reported M.D. Anderson Cancer Center 110 participants Est. completion 2028-12-31 3 sites Stand-alone

Other conditions: Delirium, Locally Advanced Malignant Neoplasm, Metastatic Malignant Neoplasm, Recurrent Malignant Neoplasm
View official trial listing →
Terminated NCT NCT03756038

Benzodiazepines for the Reduction of Distress and Pain During and After Emergency Department Care

Not yet reported Maria Pacella 1 participants Est. completion 2019-03-27 2 sites Stand-alone

Other conditions: Acute Pain
View official trial listing →
Withdrawn NCT NCT03788889

Alcohol Withdrawal Syndrome Treated With Adjunctive Phenobarbital or Ketamine

Not yet reported Santa Barbara Cottage Hospital Est. completion 2019-04-12

Other conditions: Alcohol Withdrawal Syndrome
View official trial listing →
Completed NCT NCT03829839

Effects of Oxytocin and Lorazepam on Fear-related Intra-amygdalar Activity

Not yet reported University Hospital, Bonn 120 participants Est. completion 2017-08-16 1 site

Other conditions: Oxytocin, Lorazepam, Anti-Anxiety Agents, Physiological Effects of Drugs
View official trial listing →
Completed NCT NCT03905798

LORA-PITA IV General Investigation

Pfizer 206 participants Est. completion 2023-11-15 1 site

Other conditions: Status Epilepticus
View official trial listing →
Completed NCT NCT04004416

Multi-modal Assessment of Gamma-aminobutyric Acid (GABA) Function in Psychosis

Not yet reported University of Michigan 143 participants Est. completion 2025-02-28 1 site Stand-alone

Other conditions: Schizophrenia, Bipolar Disorder, Healthy, Psychosis, Schizophreniform Disorders, Schizo Affective Disorder, Major Depression With Psychotic Features
View official trial listing →
Status unknown NCT NCT04156464

Phenobarbital vs Ativan for Alcohol Withdrawal in the Intensive Care Unit

Not yet reported OSF Healthcare System 142 participants Est. completion 2022-03-01 1 site

Other conditions: Alcohol Withdrawal, Alcohol Withdrawal Delirium
View official trial listing →
Completed NCT NCT04240626

Multimodal Analgesia Effect on Post Surgical Patient

Not yet reported University of California, Davis 60 participants Est. completion 2025-06-24 1 site Stand-alone

Other conditions: Obesity, Morbid, Surgery, Bariatric Surgery Candidate
View official trial listing →
Completed NCT NCT04274361

Ketamine for Pain Control After Severe Traumatic Injury

Not yet reported Medical College of Wisconsin 93 participants Est. completion 2025-02-28 1 site Stand-alone

Other conditions: Hospital Inpatient Trauma Injury, Pain Management
View official trial listing →
Not yet recruiting NCT NCT04396327

SM-1 vs. an Active Comparator in A Model of Transient Insomnia

Not yet reported Sequential Medicine Ltd 14 participants Est. completion 2020-06-30 1 site Stand-alone

Other conditions: Transient Insomnia
View official trial listing →
Status unknown NCT NCT04646135

Lorazepam for the Analgosedation of Pediatric Patients in Mechanical Ventilation.

Not yet reported Bambino Gesù Hospital and Research Institute 9 participants Est. completion 2021-12 Stand-alone

Other conditions: Analgesia
View official trial listing →
Withdrawn NCT NCT04671836

Lorazepam Effects on Neuroimaging Measures

Not yet reported Northwell Health Est. completion 2022-12 1 site Stand-alone

Other conditions: Lorazepam, Neuroimaging
View official trial listing →
Terminated NCT NCT04715230

Meth-OD: A Study of IXT-m200 in Patients With Toxicity From Methamphetamine Overdose

Not yet reported InterveXion Therapeutics, LLC 20 participants Est. completion 2022-11-14 4 sites

Other conditions: Methamphetamine Intoxication (Disorder)
View official trial listing →
Completed NCT NCT04828226

Clonidine to Prevent Delirium After Electroconvulsive Therapy.

Not yet reported Insel Gruppe AG, University Hospital Bern 130 participants Est. completion 2026-05-16 1 site Stand-alone

Other conditions: Major Depressive Disorder, Catatonia, Bipolar Disorder, Delirium Postseizure
View official trial listing →
Active, not recruiting NCT NCT04923659

Pharmacological Mechanisms of Low-intensity Focused Ultrasound for Motor Cortex Neuroplasticity

Not yet reported University Health Network, Toronto 20 participants Est. completion 2026-05 1 site Stand-alone

Other conditions: Low Intensity Focussed Ultrasound
View official trial listing →
Withdrawn NCT NCT05102331

Lavender Oil Aromatherapy for The Treatment of Acute Anxiety During Bone Marrow Biopsy Procedures

Not yet reported Case Comprehensive Cancer Center Est. completion 2022-08 Stand-alone

Other conditions: Hematologic Diseases
View official trial listing →
Completed NCT NCT05338099

Determine the Safety and Dose of EN001 in Patients With Duchenne Muscular Dystrophy(DMD)

Not yet reported ENCell 7 participants Est. completion 2022-12-28 1 site Stand-alone

Other conditions: Duchenne Muscular Dystrophy
View official trial listing →
Completed NCT NCT05438641

Treatment of Alcohol Withdrawal Syndrome With Alpha-2 Agonists and/or Anticonvulsants

Stanford University 30 participants Est. completion 2017-08 1 site

Other conditions: Alcohol Withdrawal Syndrome
View official trial listing →
Completed NCT NCT05521971

The Impact of a Pharmacist Intervention on Post-discharge Hypnotic Drug Discontinuation in Geriatric Inpatients

Not yet reported Universitaire Ziekenhuizen KU Leuven 173 participants Est. completion 2019-09-19 Stand-alone

Other conditions: Hypnotic Withdrawal
View official trial listing →
Status unknown NCT NCT05599126

A Study of Mianserin in Combination With SSRIs in Depression With Sleep Problems

Not yet reported Zhenghui YI 300 participants Est. completion 2025-12-30 1 site

Other conditions: Depression
View official trial listing →
Status unknown NCT NCT05600790

Mechanism of Mindfulness Based Online Intervention in Reducing Emotional Distress

Not yet reported Peking University 300 participants Est. completion 2023-02-28 1 site

Other conditions: Emotional Distress
View official trial listing →
Status unknown NCT NCT05606224

The Effects and Mechanisms of Mindfulness Intervention for Emotional Distress

Not yet reported Peking University 200 participants Est. completion 2023-08-30 4 sites

Other conditions: Emotional Disorder
View official trial listing →
Completed NCT NCT05662228

Therapies for Down Syndrome Regression Disorder

Not yet reported University of Colorado, Denver 66 participants Est. completion 2026-05-28 2 sites Stand-alone

Other conditions: Down Syndrome, Regression
View official trial listing →
Not yet recruiting NCT NCT05737511

Efficacy of Hydroxyzine for Patients With Panic Disorder

Not yet reported Sultan Qaboos University 80 participants Est. completion 2026-12-30

Other conditions: Panic Disorder
View official trial listing →
Status unknown NCT NCT05891015

The Mechanism of Mindfulness Intervention to Alleviate Emotional Distress in Patients With Emotional Disorders

Not yet reported Peking University 200 participants Est. completion 2025-12-15 1 site

Other conditions: Emotional Distress, Emotional Disorder
View official trial listing →
Completed NCT NCT05964647

Effect of Ketanserin, Olanzapine, and Lorazepam After LSD Administration on the Acute Response to LSD in Healthy Subjects

Not yet reported University Hospital, Basel, Switzerland 20 participants Est. completion 2025-06-30 1 site

Other conditions: Healthy
View official trial listing →
Status unknown NCT NCT06035003

Mechanism of Mindfulness-Based Online Intervention in Enhancing Cognitive Flexibility

Not yet reported Peking University 595 participants Est. completion 2024-02-28 1 site

Other conditions: Emotional Distress
View official trial listing →
Status unknown NCT NCT06093451

Evaluating Sublingual Dexmedetomidine For Moderate To Severe Agitation In Inpatients With Schizophrenia Or Bipolar Disorder

Not yet reported Temple University 32 participants Est. completion 2024-07-01 1 site

Other conditions: Schizophrenia Agitation, Schizo Affective Disorder, Bipolar Disorder, Dexmedetomidine
View official trial listing →
Status unknown NCT NCT06223191

Reducing Readmissions: BNI Trial in Substance Use Disorder

Not yet reported Universidad Nacional Autonoma de Honduras 150 participants Est. completion 2024-09-15 1 site

Substance use disorder Other conditions: Substance Withdrawal
View official trial listing →
Status unknown NCT NCT06370442

Intranasal Dexmedetomidine vs. Standard of Care for Emergency Department (ED) Procedural Sedation in the Older Adult

Not yet reported State University of New York - Upstate Medical University 60 participants Est. completion 2025-09-01

Other conditions: Altered Mental Status
View official trial listing →
Suspended NCT NCT06429657

Ketamine for Sedation in Severe Traumatic Brain Injury

Not yet reported Henry M. Jackson Foundation for the Advancement of Military Medicine 50 participants Est. completion 2027-06-30 1 site

Other conditions: Severe Traumatic Brain Injury, Intracranial Hypertension, Intracranial Hemorrhage, Hypertensive
View official trial listing →
Withdrawn NCT NCT06496854

Prescribing Lorazepam for IUD Insertion: Pilot Feasibility Study

Not yet reported University of Wisconsin, Madison Est. completion 2026-01 1 site Stand-alone

Other conditions: Pain, IUD
View official trial listing →
Not yet recruiting NCT NCT07017452

Trial to Assess the Efficacy and Safety During Convective Radiofrequency Water Vapor Thermal Therapy (REZUM) for Benign Prostate Hyperplasia

Not yet reported University of Manitoba 48 participants Est. completion 2026-06 1 site Stand-alone

Other conditions: Benign Prostate Hypertrophy(BPH)
View official trial listing →
Not yet recruiting NCT NCT07173231

Use of VR for Diagnostic Hysteroscopy

Not yet reported St. Justine's Hospital 45 participants Est. completion 2026-03

Other conditions: Hysteroscopy, Anxiety, Pain
View official trial listing →
Active, not recruiting NCT NCT07179978

Lorazepam and the Risk of Serious Adverse Events

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 12308 participants Est. completion 2027-12-31 1 site

Chronic kidney disease
View official trial listing →
Not yet recruiting NCT NCT07428681

Lorazepam for Delirium Prevention in Critically Ill Patients With High Anttila-Index

Not yet reported University Hospital, Basel, Switzerland 260 participants Est. completion 2029-02 Stand-alone

Other conditions: Delirium Confusional State
View official trial listing →
Not yet recruiting NCT NCT07660952

Effect of IE Glasses on MRI Patient Outcomes

Not yet reported Baptist Health South Florida 300 participants Est. completion 2027-07-01

Other conditions: MRI-related Anxiety, MRI Completion Rate
View official trial listing →

Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

ClinicalTrials.gov — NCT04240626

Also known as: Lorazepam, Ativan

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.